NCT03003962 2026-03-11Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)AstraZenecaPhase 3 Active not recruiting669 enrolled 54 charts
NCT03519971 2025-10-28Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung CancerAstraZenecaPhase 3 Active not recruiting328 enrolled 23 charts